Drug · DIN 02473909
BESPONSA
SINGLE-DOSE VIAL
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since May 3, 2018; first marketed May 3, 2018.
- Drug Identification Number (DIN)
- 02473909
- Company (DIN owner)
- Pfizer Canada UlcKirkland, Quebec, Canada
- Schedule
- Prescription; Schedule d
- Dosage form
- Powder For Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Inotuzumab ozogamicin L01FB01
- Class
- Human
- Record last updated
- August 7, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| INOTUZUMAB OZOGAMICIN | 0.9 MG | VIAL |